Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Forest Labs Net Falls On Generic Competition To Lexapro
Bloomberg
Tuesday, July 17, 2012 - 12:35pm
tags:
earnings, Forest Labs
Merck stock hits new 52-week high
TheStreet.com
Tuesday, July 17, 2012 - 12:28pm
tags:
Merck
Gilead Faces Big Issues With AIDS Vaccine
Seeking Alpha
Tuesday, July 17, 2012 - 12:22pm
tags:
Truvada, HIV, AIDS, Gilead, vaccines
StemCells rockets 40% on Alzheimer's study
Marketwatch
Tuesday, July 17, 2012 - 12:18pm
tags:
Alzheimer's disease, StemCells
Baxter Alzheimer's drug keeps four patients stable for 3 years
Reuters
Tuesday, July 17, 2012 - 11:54am
tags:
Baxter, Alzheimer's disease, Gammagard
Teva/Active Biotech MS pill accepted for review in Europe
Pharma Times, UK
Tuesday, July 17, 2012 - 11:43am
tags:
Teva Pharmaceuticals, Active Biotech, MS, multiple sclerosis, Europe
Diet drug makers Vivus and Orexigen fall ahead of FDA decision
Reuters
Tuesday, July 17, 2012 - 11:27am
tags:
Vivus, Orexigen, Contrave, obesity, Qnexa
Alnylam Pushes Forward In Amyloidosis After Pfizer Setback
Seeking Alpha
Tuesday, July 17, 2012 - 11:08am
tags:
Alnylam, amyloidosis, Pfizer, ALN-TTR02
Transition Therapeutics Awaiting Competing AD Trial Results
Seeking Alpha
Tuesday, July 17, 2012 - 10:48am
tags:
Transition Therapeutics, Elan, JNJ, Eli Lilly, Pfizer, Alzheimer's disease
AstraZeneca Expands Study Of Brilinta Against Plavix
Bloomberg
Tuesday, July 17, 2012 - 10:47am
tags:
AstraZeneca, Plavix, Brilinta, bloodthinners
Glaxo's revenue/profit should start growing again this year, Barron's contends
Yahoo/Fly on the Wall
Tuesday, July 17, 2012 - 10:46am
tags:
GSK
J&J Q2 sales lag, profit view cut on forex factors
Reuters
Tuesday, July 17, 2012 - 10:44am
tags:
JNJ, earnings
Chugai earmarks $150M for antibody research in Singapore
Fierce Biotech
Monday, July 16, 2012 - 7:44pm
tags:
R&D, Chugai, Singapore
In confidence survey, VCs sound lukewarm about biotech
Fierce Biotech
Monday, July 16, 2012 - 7:43pm
tags:
venture capital
Ex-AstraZeneca chief forfeits up to £3.5M in exit pay
Fierce Pharma
Monday, July 16, 2012 - 7:36pm
tags:
executive pay, AstraZeneca, David Brennan
Sequenom, Inc. Files Notice Of Appeal Of Preliminary Injunction Denial
Yahoo
Monday, July 16, 2012 - 7:34pm
tags:
Sequenom
Schering-Plough’s K-Dur Pay-For-Delay Ruling Reversed
Bloomberg
Monday, July 16, 2012 - 7:32pm
tags:
Schering Plough, pay-for-delay, K-Dur, Merck
Abbott Labs’ Second Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Monday, July 16, 2012 - 7:31pm
tags:
earnings, Abbott Laboratories
Antitrust regulators tell Novartis to sell 4 skin care products as part of $1.5B Fougera deal
Yahoo/AP
Monday, July 16, 2012 - 7:31pm
tags:
FTC, Novartis, Fougera
Vivus, Orexigen climb ahead of FDA decision
Marketwatch
Monday, July 16, 2012 - 2:02pm
tags:
Orexigen, FDA, obesity, Vivus, Qnexa, Contrave

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.